|
del Mar Osma M, Gonzalez-Billalabeitia E, Ortuño FJ, Jerez A, Ayala F, Vicente V. Transient massive peripheral blood blastosis in patient with renal clear-cell carcinoma after treatment with high-dose recombinant interleuklin-2. Lancet Oncol. 2007 Mar;8(3):275-6. PubMed PMID: 17329199.
AÑO: 2007; IF: 12.247
|
17329199
|
Zafra M, Ayala F, Gonzalez-Billalabeitia E, Vicente E, Gonzalez-Cabezas P, García T, Macías JA, Vicente V. Impact of whole-body 18F-FDG PET on diagnostic and therapeutic management of Medical Oncology patients. Eur J Cancer. 2008 Aug;44(12):1678-83. doi: 10.1016/j.ejca.2008.05.021. Epub 2008 Jul 7. PubMed PMID: 18614352.
AÑO: 2008; IF: 4.475
|
|
Cascales A, Sánchez-Vega B, Navarro N, Pastor-Quirante F, Corral J, Vicente V, de la Peña FA. Clinical and genetic determinants of anthracycline-induced cardiac iron accumulation. Int J Cardiol. 2012 Feb 9;154(3):282-6. doi: 10.1016/j.ijcard.2010.09.046. Epub 2010 Oct 25. PubMed PMID: 20974500.
AÑO: 2012; IF: 5.509
|
|
Carmona-Bayonas A, Gómez J, González-Billalabeitia E, Canteras M, Navarrete A, Gonzálvez ML, Vicente V, Ayala de la Peña F. Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients. Br J Cancer. 2011 Aug 23;105(5):612-7. doi: 10.1038/bjc.2011.284. Epub 2011 Aug 2. PubMed PMID: 21811253; PubMed Central PMCID: PMC3188929.
AÑO: 2011; IF: 5.042
|
|
Vicente Conesa MA, Garcia-Martinez E, Gonzalez Billalabeitia E, Chaves Benito A, Garcia Garcia T, Vicente Garcia V, Ayala de la Peña F. Predictive value of peripheral blood lymphocyte count in breast cancer patients treated with primary chemotherapy. Breast. 2012 Aug;21(4):468-74. doi: 10.1016/j.breast.2011.11.002. Epub 2011 Nov 26. PubMed PMID: 22119767.
AÑO: 2012; IF: 1.967
|